Spots Global Cancer Trial Database for propranolol
Every month we try and update this database with for propranolol cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Nadolol Versus Propranolol in Children With Infantile Hemangiomas | NCT02505971 | Infantile Heman... | Nadolol Propranolol | 1 Month - 6 Months | The Hospital for Sick Children | |
| A Trial of EVL\GVS Alone vs. EVL\GVS Combined Propranolol (S-HCC) | NCT01451658 | Gastroesophagea... Hepatocellular ... | propranolol | 18 Years - 80 Years | Taipei Veterans General Hospital, Taiwan | |
| Therapeutic Targeting of Stress Factors in Ovarian Cancer Patients | NCT01308944 | Invasive Epithe... Primary Periton... Fallopian Tube ... | Propranolol | 18 Years - | Washington University School of Medicine | |
| Efficacy and Safety of Propranolol Versus Atenolol on the Proliferative Phase of Infantile Hemangioma | NCT02342275 | Hemangioma | Propranolol Atenolol | - 24 Weeks | West China Hospital | |
| Sirolimus in the Treatment for Infantile Hepatic Hemangioendothelioma(IEEH) | NCT04406870 | Hemangioendothe... | Sirolimus Oral ... propranolol | 1 Month - 36 Months | Shanghai Children's Medical Center | |
| Nadolol Versus Propranolol in Children With Infantile Hemangiomas | NCT02505971 | Infantile Heman... | Nadolol Propranolol | 1 Month - 6 Months | The Hospital for Sick Children | |
| Perioperative Intervention to Reduce Metastatic Processes in Pancreatic Cancer Patients Undergoing Curative Surgery | NCT03838029 | Pancreatic Neop... | Propranolol and... Placebo | 20 Years - 80 Years | Assaf-Harofeh Medical Center | |
| The Safety and Efficiency of Propranolol as an Initial Treatment for Pediatric Hemangioma | NCT01908972 | Hemangioma | Prednisolone Propranolol | - 9 Months | Seoul National University Hospital | |
| A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE) | NCT05429970 | Ovarian Cancer Ovarian Carcino... Stage II Ovary ... Stage II Ovaria... Stage III Ovary... Stage III Ovari... Stage IV Ovary ... Stage IV Ovaria... Epithelial Ovar... Fallopian Tube ... Stage II Fallop... Stage III Fallo... Stage IV Fallop... Primary Periton... | Mind-body resil... Music therapy Propranolol Etodolac | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Propranolol and Pembrolizumab in Advanced Soft Tissue Sarcoma Patients | NCT05961761 | Soft Tissue Sar... Angiosarcoma Undifferentiate... | Propranolol Pembrolizumab | 18 Years - | Herlev and Gentofte Hospital | |
| Naltrexone and Propranolol Combined With Immunotherapy | NCT05968690 | Advanced Melano... | Propranolol Naltrexone | 18 Years - | Rutgers, The State University of New Jersey | |
| Therapeutic Targeting of Stress Factors in Ovarian Cancer Patients | NCT01308944 | Invasive Epithe... Primary Periton... Fallopian Tube ... | Propranolol | 18 Years - | Washington University School of Medicine | |
| Durvalumab and Tremelimumab in Combination With Propranolol and Chemotherapy for Treatment of Advanced Hepatopancreabiliary Tumors (BLOCKED) | NCT05451043 | Pancreatic Canc... Hepatocellular ... Biliary Tract C... Cholangiocarcin... | Durvalumab Gemcitabine Nab paclitaxel Tremelimumab Propranolol Cisplatin | 18 Years - | AHS Cancer Control Alberta | |
| Sirolimus in the Treatment for Infantile Hepatic Hemangioendothelioma(IEEH) | NCT04406870 | Hemangioendothe... | Sirolimus Oral ... propranolol | 1 Month - 36 Months | Shanghai Children's Medical Center | |
| Role of Propranolol as Compared to Bleomycin in Management of Hemangioma | NCT05327309 | Hemangioma Propranolol | Bleomycin | 6 Months - 12 Months | Shaheed Zulfiqar Ali Bhutto Medical University | |
| Clinical Study of Propranolol Combined With Neoadjuvant Chemotherapy in Gastric Cancer | NCT04005365 | Gastric Cancer | Propranolol | 18 Years - 75 Years | Central South University | |
| ''Efficacy of Propranolol in the Treatment of Infantile Hemangioma" | NCT04684667 | Infantile Heman... | Propranolol The... | 1 Day - 1 Year | Assiut University | |
| Efficacy Evaluation of Propranolol Treatment of Hepatic Hemangioma | NCT03633747 | Hemangioma Live... | Propranolol Hyd... | 18 Years - 65 Years | Second Affiliated Hospital, School of Medicine, Zhejiang University | |
| Study of Propranolol in Newly Diagnosed Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy | NCT01847001 | Locally Advance... Breast Cancer | Propranolol DOT imaging Paclitaxel Nab-paclitaxel Trastuzumab Pertuzumab Doxorubicin Cyclophosphamid... Surgery Premedication Anti-nausea the... Pegfilgrastim | 18 Years - | Columbia University | |
| Propranolol Versus Prednisolone for Treatment of Symptomatic Hemangiomas | NCT00967226 | Hemangioma of I... | propranolol Prednisolone | 2 Weeks - 6 Months | Children's National Research Institute | |
| Study of Propranolol in Newly Diagnosed Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy | NCT01847001 | Locally Advance... Breast Cancer | Propranolol DOT imaging Paclitaxel Nab-paclitaxel Trastuzumab Pertuzumab Doxorubicin Cyclophosphamid... Surgery Premedication Anti-nausea the... Pegfilgrastim | 18 Years - | Columbia University | |
| Feasibility - Beta Adrenergic Blockade (BB) in Cervical Cancer (CX) | NCT01902966 | Cervical Cancer | Propranolol Diary Relaxation Audi... Questionnaires | 18 Years - | M.D. Anderson Cancer Center | |
| Sirolimus in the Treatment for Infantile Hepatic Hemangioendothelioma(IEEH) | NCT04406870 | Hemangioendothe... | Sirolimus Oral ... propranolol | 1 Month - 36 Months | Shanghai Children's Medical Center | |
| Propranolol Versus Prednisolone for Treatment of Symptomatic Hemangiomas | NCT00967226 | Hemangioma of I... | propranolol Prednisolone | 2 Weeks - 6 Months | Children's National Research Institute | |
| A Trial of EVL\GVS Alone vs. EVL\GVS Combined Propranolol (S-HCC) | NCT01451658 | Gastroesophagea... Hepatocellular ... | propranolol | 18 Years - 80 Years | Taipei Veterans General Hospital, Taiwan | |
| Evaluation of New Biomarkers Predictive of Efficacy Betablockers in PEComa and Vascular Pediatric Tumors | NCT02334930 | PEComa Hemangioma | Biopsy | - | University Hospital, Bordeaux | |
| Perioperative Intervention to Reduce Metastatic Processes in Pancreatic Cancer Patients Undergoing Curative Surgery | NCT03838029 | Pancreatic Neop... | Propranolol and... Placebo | 20 Years - 80 Years | Assaf-Harofeh Medical Center | |
| Efficacy and Safety of Propranolol Versus Acebutolol on the Proliferative Phase of Infantile Hemangioma | NCT01743885 | Hemangioma | Acebutolol Propanolol | - 6 Months | University Hospital, Montpellier | |
| Propranolol Hydrochloride in Combination With Sintilimab and Platinum-based Chemotherapy for Treatment of Advanced Non-small Cell Lung Cancer | NCT05979818 | Non Small Cell ... Propranolol | Propranolol hyd... Sintilimab Chemotherapy | 18 Years - 75 Years | Second Xiangya Hospital of Central South University | |
| The Safety and Efficiency of Propranolol as an Initial Treatment for Pediatric Hemangioma | NCT01908972 | Hemangioma | Prednisolone Propranolol | - 9 Months | Seoul National University Hospital | |
| Propranolol Administration in Pediatric Patients With Recurrent Respiratory Papillomatosis | NCT01058317 | Recurrent Respi... | Propranolol | 1 Year - 10 Years | Massachusetts Eye and Ear Infirmary | |
| Colorectal Metastasis Prevention International Trial 2 | NCT03919461 | Colorectal Neop... | Propranolol and... Placebo | 20 Years - 80 Years | Assaf-Harofeh Medical Center | |
| Dose-Finding of Propranolol in Combination With Metronomic Fixed Oral Cyclophosphamide Based on Bivariate Efficacy-tolerability Outcome in Patients With Locally Advanced or Metastatic Angiosarcoma: A Collaborative and Innovative Phase I-II Sequential Trial by the French Sarcoma Group (GSF/GETO) | NCT02732678 | Angiosarcoma | PROPRANOLOL | 15 Years - | Assistance Publique Hopitaux De Marseille | |
| A Study of Propranolol to Treat Kaposi Sarcoma | NCT05797662 | Kaposi Sarcoma | Propranolol | - | AIDS Malignancy Consortium | |
| Efficacy of Propranolol Treatment to Prevent Melanoma Progression | NCT01988831 | Stages III Skin... Stages II Skin ... Stage IB Skin M... | Propranolol hyd... Placebo pill | 18 Years - | University Hospital, Geneva | |
| Bevacizumab vs Dacarbazine in Metastatic Melanoma | NCT01705392 | Metastatic Mali... Unresectable Ma... | Bevacizumab Propranolol Enalapril Dacarbazine | 18 Years - | Haukeland University Hospital | |
| Propranolol in Capillary Hemangiomas | NCT00744185 | Hemangioma, Cap... | propranolol tre... placebo treatme... | - 4 Months | University Hospital, Bordeaux | |
| Corticosteroids With Placebo Versus Corticosteroids With Propranolol Treatment of Infantile Hemangiomas (IH) | NCT01074437 | Hemangioma | Prednisolone (C... Propranolol Placebo | - 9 Months | Seattle Children's Hospital | |
| Off Label Use of Propranolol for Infancy Hemangiomas | NCT01211080 | Hemangioma | Propranolol | 1 Month - 8 Months | Hannover Medical School | |
| Colorectal Metastasis Prevention International Trial 2 | NCT03919461 | Colorectal Neop... | Propranolol and... Placebo | 20 Years - 80 Years | Assaf-Harofeh Medical Center | |
| Off Label Use of Propranolol for Infancy Hemangiomas | NCT01211080 | Hemangioma | Propranolol | 1 Month - 8 Months | Hannover Medical School | |
| Treatment of Renal Angiomyolipomas in Tuberous Sclerosis by Beta-blockers | NCT02104011 | Renal Angiomyol... Tuberous Sclero... | Propranolol | 18 Years - | University Hospital, Bordeaux | |
| Durvalumab and Tremelimumab in Combination With Propranolol and Chemotherapy for Treatment of Advanced Hepatopancreabiliary Tumors (BLOCKED) | NCT05451043 | Pancreatic Canc... Hepatocellular ... Biliary Tract C... Cholangiocarcin... | Durvalumab Gemcitabine Nab paclitaxel Tremelimumab Propranolol Cisplatin | 18 Years - | AHS Cancer Control Alberta | |
| A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE) | NCT05429970 | Ovarian Cancer Ovarian Carcino... Stage II Ovary ... Stage II Ovaria... Stage III Ovary... Stage III Ovari... Stage IV Ovary ... Stage IV Ovaria... Epithelial Ovar... Fallopian Tube ... Stage II Fallop... Stage III Fallo... Stage IV Fallop... Primary Periton... | Mind-body resil... Music therapy Propranolol Etodolac | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| MELABLOCK: A Clinical Trial on the Efficacy and Safety of Propranolol 80 mg in Melanoma Patients | NCT02962947 | Melanoma | Propranolol Placebo | 18 Years - 75 Years | Azienda Sanitaria di Firenze | |
| Propranolol Versus Prednisolone for Treatment of Symptomatic Hemangiomas | NCT00967226 | Hemangioma of I... | propranolol Prednisolone | 2 Weeks - 6 Months | Children's National Research Institute | |
| Ph2, Study to Assess the Safety and Efficacy of GPC 100 and Propranolol With and Without G-CSF for the Mobilization of Stem Cells in Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant | NCT05561751 | Multiple Myelom... | GPC-100 Propranolol G-CSF | 18 Years - | GPCR Therapeutics, Inc. | |
| Perioperative Propranolol During Prostatectomy to Decrease Cancer Recurrence | NCT05679193 | Prostate Cancer | Propranolol | 40 Years - 80 Years | Oslo University Hospital | |
| Ontogeny of Infantile Hemangiomas With Skin Imaging Modalities | NCT02061735 | Infantile Heman... | 1 Month - 5 Years | Children's Hospital Medical Center, Cincinnati | ||
| A Trial of EVL\GVS Alone vs. EVL\GVS Combined Propranolol (S-HCC) | NCT01451658 | Gastroesophagea... Hepatocellular ... | propranolol | 18 Years - 80 Years | Taipei Veterans General Hospital, Taiwan | |
| Study of Propranolol in Newly Diagnosed Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy | NCT01847001 | Locally Advance... Breast Cancer | Propranolol DOT imaging Paclitaxel Nab-paclitaxel Trastuzumab Pertuzumab Doxorubicin Cyclophosphamid... Surgery Premedication Anti-nausea the... Pegfilgrastim | 18 Years - | Columbia University | |
| Ontogeny of Infantile Hemangiomas With Skin Imaging Modalities | NCT02061735 | Infantile Heman... | 1 Month - 5 Years | Children's Hospital Medical Center, Cincinnati | ||
| Propranolol Hydrochloride in Combination With Sintilimab and Platinum-based Chemotherapy for Treatment of Advanced Non-small Cell Lung Cancer | NCT05979818 | Non Small Cell ... Propranolol | Propranolol hyd... Sintilimab Chemotherapy | 18 Years - 75 Years | Second Xiangya Hospital of Central South University | |
| Clinical Research on Teratment of Gastrointestinal Cancer in the Preoperative by Propranolol | NCT03245554 | Gastrointestina... | Propranolol | 18 Years - 60 Years | Central South University | |
| Bevacizumab vs Dacarbazine in Metastatic Melanoma | NCT01705392 | Metastatic Mali... Unresectable Ma... | Bevacizumab Propranolol Enalapril Dacarbazine | 18 Years - | Haukeland University Hospital | |
| Comparative Study of the Use of Beta Blocker and Oral Corticosteroid in the Treatment of Infantile Hemangioma | NCT01072045 | Hemangioma | Propranolol Prednisone | 10 Days - 2 Years | University of Sao Paulo | |
| ''Efficacy of Propranolol in the Treatment of Infantile Hemangioma" | NCT04684667 | Infantile Heman... | Propranolol The... | 1 Day - 1 Year | Assiut University | |
| Naltrexone and Propranolol Combined With Immunotherapy | NCT05968690 | Advanced Melano... | Propranolol Naltrexone | 18 Years - | Rutgers, The State University of New Jersey |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
